Suchergebnisse - "Pérez-Belmonte, Luis M"

PubPharm (4)

1

Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

enthalten in: Journal of the American Geriatrics Society | 2022

von Pérez-Belmonte, L. | Sanz-Cánovas, J. | Millán-Gómez, M. | +9

CommentIn: J Am Geriatr Soc. 2022 May;70(5):1585-1589. - PMID 35174486

2

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular and renal protection : A treatment approach far beyond their glucose-lowering effect

enthalten in: European journal of internal medicine | 2022

von Gómez-Huelgas, R. | Sanz-Cánovas, J. | Cobos-Palacios, L. | +2

CommentIn: Eur J Intern Med. 2022 Apr;98:125-127. - PMID 34969593

3

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs : a nationwide cohort study

enthalten in: BMC medicine | 2020

von Pérez-Belmonte, L. | Torres-Peña, J. | López-Carmona, M. | +23

4

Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly. Authors' reply

enthalten in: Polish archives of internal medicine | 2019

von Gómez-Huelgas, R. | Pérez-Belmonte, L. | López-Sampalo, A. | +3

CommentOn: Pol Arch Intern Med. 2019 Feb 28;129(2):137-140. - PMID 30600309

1
[1]